ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 92 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,206,000 | +111.1% | 50,544 | -11.8% | 0.16% | +83.7% |
| Q2 2019 | $1,519,000 | +32.0% | 57,325 | -8.6% | 0.09% | +24.6% |
| Q1 2019 | $1,151,000 | +21.7% | 62,725 | -17.6% | 0.07% | +13.1% |
| Q4 2018 | $946,000 | -60.5% | 76,159 | -56.8% | 0.06% | -37.1% |
| Q2 2018 | $2,395,000 | +230.8% | 176,170 | +75.3% | 0.10% | +234.5% |
| Q1 2018 | $724,000 | -3.2% | 100,470 | -50.6% | 0.03% | -12.1% |
| Q4 2017 | $748,000 | -25.6% | 203,270 | -12.6% | 0.03% | -35.3% |
| Q3 2017 | $1,006,000 | +137.3% | 232,470 | +1.3% | 0.05% | +155.0% |
| Q1 2017 | $424,000 | +45.2% | 229,590 | +317.9% | 0.02% | +33.3% |
| Q2 2016 | $292,000 | – | 54,943 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |